[1]黄学卿,王黎洲,周 石,等.血管重建治疗血液透析并发下肢动脉硬化闭塞症患者预后分析[J].介入放射学杂志,2017,(01):118-122.
 HUANG Xueqing,WANG Lizhou,ZHOU Shi,et al.Vascular remodeling for the treatment of hemodialysis patients complicated with arteriosclerosis obliterans of lower extremity: analysis of prognosis[J].journal interventional radiology,2017,(01):118-122.
点击复制

血管重建治疗血液透析并发下肢动脉硬化闭塞症患者预后分析 ()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
期数:
2017年01期
页码:
118-122
栏目:
血管介入
出版日期:
2017-01-25

文章信息/Info

Title:
Vascular remodeling for the treatment of hemodialysis patients complicated with arteriosclerosis obliterans of lower extremity: analysis of prognosis
作者:
黄学卿 王黎洲 周 石 李 兴 蒋天鹏 宋 杰
Author(s):
HUANG Xueqing WANG Lizhou ZHOU Shi LI Xing JIANG Tianpeng SONG Jie
Department of Interventional Radiology, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou Province 550004, China
关键词:
【关键词】 经皮腔内血管成形术 血液透析预后 动脉硬化闭塞症
文献标志码:
A
摘要:
【摘要】 目的 探讨血液透析(HD)并发下肢动脉硬化闭塞症(ASO)患者临床特征及经皮腔内血管成形术(PTA)治疗预后的影响因素。方法 回顾性分析2008年1月至2015年10月收治的211例有或无HD治疗的下肢ASO患者临床资料,所有患者均成功接受PTA术。结果 中位随访时间为2.24年,有HD治疗组无截肢生存较差于无HD治疗组(P<0.000 1),术后一期通畅率明显低于无HD治疗组(P=0.000 4)。两组间无截肢生存率影响因素并不相同,有HD治疗组独立影响因素为糖尿病,无HD治疗组独立影响因素为Fontaine分期及高脂血症。有HD治疗组中术后感染死亡率(10/18,55.5%)高于无HD治疗组(6/26,22.2%)(P<0.05)。结论 PTA术治疗HD并发下肢ASO患者预后较差于非HD并发ASO患者,糖尿病可能是影响预后的独立因素。

参考文献/References:

[1] Wolfle KD, Bruijnen H, Loeprecht H, et al. Graft patency and clinical outcome of femorodistal arterial reconstruction in diabetic and non-diabetic patients: results of a multicentre comparative analysis[J]. Eur J Vasc Endovasc Surg, 2003, 25: 229-234.
[2] van der Zaag ES, Legemate DA, Prins MH, et al. Angioplasty or bypass for superficial femoral artery disease? A randomized controlled trial[J]. Eur J Vasc Endovasc Surg, 2004, 28: 132-137.
[3] Albers M, Romiti M, Brochado-Neto FC, et al. Meta-analysis of alternate autologous vein bypass grafts to infrapopliteal arteries[J]. J Vasc Surg, 2005, 42: 449-455.
[4] Papavassiliou VG, Walker SR, Bolia A, et al. Techniques for the endovascular management of complications following lower limb percutaneous transluminal angioplasty[J]. Eur J Vasc Endovasc Surg, 2003, 25: 125-130.
[5] Black JH 3rd, La Muraglia GM, Kwolek CJ, et al. Contemporary results of angioplasty-based infrainguinal percutaneous inter-ventions[J]. J Vasc Surg, 2005, 42: 932-939.
[6] Adam DJ, Beard JD, Cleveland T, et al. Bypass versus angioplasty in severe ischaemia of the leg(BASIL): multicentre, randomised controlled trial[J]. Lancet, 2005, 366: 1925-1934.
[7] Kimura H, Miyata T, Sato O, et al. Infrainguinal arterial reconstruction for limb salvage in patients with end-stage renal disease[J]. Eur J Vasc Endovasc Surg, 2003, 25: 29-34.
[8] Hakaim AG, Gordon JK, Scott TE. Early outcome of in situ femorotibial reconstruction among patients with diabetes alone versus diabetes and end-stage renal failure: analysis of 83 limbs[J]. J Vasc Surg, 1998, 27: 1049-1054.
[9] Ramdev P, Rayan SS, Sheahan M, et al. A decade experience with infrainguinal revascularization in a dialysis-dependent patient population[J]. J Vasc Surg, 2002, 36: 969-974.
[10] Meyerson SL, Skelly CL, Curi MA, et al. Long-term results justify autogenous infrainguinal bypass grafting in patients with end-stage renal failure[J]. J Vasc Surg, 2001, 34: 27-33.
[11] Aulivola B, Gargiulo M, Bessoni M, et al. Infrapopliteal angioplasty for limb salvage in the setting of renal failure: do results justify its use?[J]. Ann Vasc Surg, 2005, 19: 762-768.
[12] 宋 杰, 王黎洲, 李 兴, 等. 顺行穿刺腔内治疗膝下动脉硬化闭塞症的疗效评估[J]. 介入放射学杂志, 2013, 22: 154-158.
[13] 中华医学会外科学分会血管外科学组. 下肢动脉硬化闭塞症诊治指南[J]. 中华普通外科学文献?电子版, 2016, 10: 1-18.
[14] Dormandy JA, Rutherford RB. Management of peripheral arterial disease(PAD). TASC Working Group. TransAtlantic Inter-Society Consensus(TASC)[J]. J Vasc Surg, 2000, 31(1 Pt 2): S1-S296.
[15] Hoshino J, Ubara Y, Ohara K, et al. Changes in the activities of daily living(ADL) in relation to thelevel of amputation of patients undergoing lower extremity amputation for arteriosclerosis obliterans (ASO)[J]. Circ J, 2008, 72: 1495-1498.
[16] Ono K, Tsuchida A, Kawai H, et al. Ankle-brachial blood pressure index predicts all-cause and cardiovascular mortality in hemodialysis patients[J]. J Am Soc Nephrol, 2003, 14: 1591-1598.
[17] Leskinen Y, Salenius JP, Lehtimaki T, et al. The prevalence of peripheral arterial disease and medial arterial calcification in patients with chronic renal failure: requirements for diagnostics[J]. Am J Kidney Dis, 2002, 40: 472-479.
[18] 李艳奎, 吴义生, 张小明. TASC-D型下肢动脉硬化闭塞症腔内治疗现状[J]. 介入放射学杂志, 2015, 24: 544-547.
[19] Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan[J]. Am J Kidney Dis, 2009, 53: 982-992.
[20] Duffield RG, Lewis B, Miller NE, et al. Treatment of hyperli-pidaemia retards progression of symptomatic femoral atherosclerosis. A randomised controlled trial[J]. Lancet, 1983, 2: 639-642.
[21] Hayashi T, Kawashima S, Itoh H, et al. Importance of lipid levels in elderly diabetic individuals: baseline characteristics and 1-year survey of cardiovascular events[J]. Circ J, 2008, 72: 218-225.
[22] Heart Protection Study Collaborative Group. MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial[J]. Lancet, 2002, 360: 7-22.

相似文献/References:

[1]朱景航,库 媛,黄学卿,等.经皮腔内血管成形术治疗血液透析动静脉内瘘狭窄效果的影响因素分析[J].介入放射学杂志,2018,27(11):1079.
 ZHU Jinghang,KU Yuan,HUANG Xueqing,et al.Percutaneous transluminal balloon angioplasty for the treatment of native hemodialysis arteriovenous fistula stenoses: analysis of factors affecting postprocedural fistula patency[J].journal interventional radiology,2018,27(01):1079.

备注/Memo

备注/Memo:
(收稿日期:2016-04-12)
(本文编辑:边 佶)
更新日期/Last Update: 2017-02-13